Next Article in Journal
Comparison of Serological Methods for the Diagnosis of Toxoplasmosis in Pregnant Women
Previous Article in Journal
A Post-Pandemic Surge: Sustained High Prevalence and Epidemiological Shift in Pediatric Epstein–Barr Virus Infection
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Commentary

Inflammatory Pathology and Mechanisms of Filamentous Fungal Infection in Breast Implants: A Commentary

by
Andrew W. Campbell
1,* and
Abdelrahman Elamin
2
1
MyMycoLab, Land O Lakes, FL 34639, USA
2
Faculty of Science and Engineering, Teikyo University, Utsunomiya 320-8551, Tochigi, Japan
*
Author to whom correspondence should be addressed.
Pathogens 2026, 15(4), 362; https://doi.org/10.3390/pathogens15040362 (registering DOI)
Submission received: 2 February 2026 / Revised: 26 March 2026 / Accepted: 27 March 2026 / Published: 29 March 2026

Abstract

Filamentous fungal infections of breast implants remain underrecognized compared with infections caused by Candida species and bacteria, despite their potential to induce significant inflammatory pathology. This commentary highlights the distinctive ability of filamentous fungal biofilms to penetrate deeply into the implant capsule, a feature that may contribute to distinct pathogenic behaviour compared with bacterial or yeast biofilms. We discuss how this invasive behavior may contribute to the perception that reported cases represent the first documented breast implant-associated fungal infections, when in fact such infections may be under-recognised and under-investigated. By drawing attention to these mechanisms and their clinical implications, this commentary aims to stimulate greater awareness and further investigation within the fields of infectious diseases and pathogen research.
Keywords: breast implant; fungi; infection; biofilm; inflammatory signs; mycotoxins; mechanism; systemic symptoms breast implant; fungi; infection; biofilm; inflammatory signs; mycotoxins; mechanism; systemic symptoms

Share and Cite

MDPI and ACS Style

Campbell, A.W.; Elamin, A. Inflammatory Pathology and Mechanisms of Filamentous Fungal Infection in Breast Implants: A Commentary. Pathogens 2026, 15, 362. https://doi.org/10.3390/pathogens15040362

AMA Style

Campbell AW, Elamin A. Inflammatory Pathology and Mechanisms of Filamentous Fungal Infection in Breast Implants: A Commentary. Pathogens. 2026; 15(4):362. https://doi.org/10.3390/pathogens15040362

Chicago/Turabian Style

Campbell, Andrew W., and Abdelrahman Elamin. 2026. "Inflammatory Pathology and Mechanisms of Filamentous Fungal Infection in Breast Implants: A Commentary" Pathogens 15, no. 4: 362. https://doi.org/10.3390/pathogens15040362

APA Style

Campbell, A. W., & Elamin, A. (2026). Inflammatory Pathology and Mechanisms of Filamentous Fungal Infection in Breast Implants: A Commentary. Pathogens, 15(4), 362. https://doi.org/10.3390/pathogens15040362

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop